Have £1,000 to invest? This FTSE 100 dividend growth stock could help you to retire early

Royston Wild looks at a FTSE 100 (INDEXFTSE: UKX) income star that could make you a fortune.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’ve said it before: those looking over the FTSE 100 for exceptional stocks raising dividends at a rate of knots could do a lot worse than to splash the cash on Intertek Group (LSE: ITRK).

My opinion that the assurance, testing, inspection and certification services provider is a brilliant buy remains unchanged despite the chilly reception to latest trading numbers released on Tuesday. Investors reacted badly to the news that revenues dropped by a bigger-than-expected 1.8% during the January-June period, with lower year-on-year sales of £1.35bn reflecting severe currency headwinds and slowing sales at its Products and Resources divisions.

It’s worth noting, however, that organic revenue still rose 3.4% in the period. Sure, this indicates a reduction in recent months — sales on a comparable basis had increased 4% in the first four months of 2018 — but this can in some part be attributed to the loss of a working day in the last half.

Acquisitions keep on coming

The bearish sentiment washing around this week does not feel right for of a company whose sales performance remains broadly robust, and whose position in the massive global quality assurance industry (which Intertek values at $250bn) is growing thanks to its dedication to M&A.

It made another three acquisitions in the first half of 2018 to build its geographical and operational footprint, and made a huge statement with the $480m purchase of North America’s Alchemy Investment Holdings, a big player in the food industry’s people assurance segment.

It’s no surprise that the City is still expecting earnings to keep rattling higher despite the top-line reversal of the first half, although admittedly predicted rises of 2% in 2018 and 8% in 2019 aren’t enough to get pulses racing. What is, though, is the rate at which dividends are expected to advance, with current forecasts being buoyed by Intertek’s decision to hike the interim dividend by more than a third year-on-year to 31.9p.

This upsurge reflects the company’s decision last year to raise the dividend payout ratio to 50% from 2018, the ambitious target supported by its strong growth outlook and its exceptional cash generation (free cash flow clocked in at £90.6m between January and June).

Dividends striding higher

And so back to those dividend forecasts: presently the number crunchers are anticipating that last year’s total payout of 71.3p per share will jump to 90.4p in the current period, and again to 98.2p in 2019.

Subsequent yields of 1.7% and 1.8% for these respective years may be handy rather than spectacular, but the rate at which Intertek looks likely to keep growing dividends should excite the interest of long-term investors.

It’s a dead cert that Intertek’s high valuation prompted Tuesday’s 10% share price slide. And even despite the sell-off, the company still sports a forward P/E ratio of 27.2 times, almost double the widely-accepted value benchmark of 15 times.

I retain my bullish take on the business even with its still-hefty rating, however, and reckon the recent pullback is a splendid buying opportunity.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended Intertek. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »